HHealthcare Read More 2 Top AI Healthcare Stocks to Buy and HoldMarch 9, 2026 Many of the top companies successfully cashing in on artificial intelligence (AI) are in the technology sector. However,…
HHealthcare Read More Eli Lilly on track to launch oral obesity drug in second quarter, pending US approvalMarch 5, 2026 March 2 (Reuters) – Eli Lilly CFO Lucas Montarce said on Monday it is preparing to launch its…
HHealthcare Read More The Best Healthcare Stock to Invest $1,000 in Right NowMarch 3, 2026 When you think “top-performing pharma stock,” Eli Lilly may first come to mind. Yet while Lilly’s shares have…
MMedication Read More 1 Reason Why I’d Hold This Weight‑Loss Drug Leader Through Any Market CrashFebruary 26, 2026 Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) are locked in a battle around GLP-1 weight-loss drugs.…
EEconomy Read More Why haven’t Trump’s tariffs caused a downturn in the US? – The Irish TimesFebruary 22, 2026 When Donald Trump famously announced his Liberation Day tariff assault on the world last April, economists, almost en…
MMedication Read More NHS must keep medicine rebate down or lose investmentFebruary 19, 2026 Wednesday 18 February 2026 2:27 pm | Updated: Wednesday 18 February 2026 3:10 pm Share Facebook Share on Facebook…
HHealthcare Read More JPMorgan builds $2.93 billion stake in health care stockFebruary 17, 2026 JPMorgan Chase just planted a massive $2.93 billion flag in perhaps one of the hottest corners of the…
AArtificial intelligence Read More This Pharma Giant Is Using AI to Dominate Drug DiscoveryFebruary 16, 2026 There’s no denying modern-day artificial intelligence (AI) is doing some pretty cool stuff. But, to say it’s been…
HHealthcare Read More What’s the Better Long-Term Investment?February 10, 2026 Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) are rivals in the GLP-1 drug market and are…
HHealthcare Read More Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.February 8, 2026 Eli Lilly’s (NYSE: LLY) stock has risen 225% over the past three years. That trounces the S&P 500’s (SNPINDEX:…
HHealthcare Read More The most controversial Super Bowl ad of 2025 is back for moreFebruary 7, 2026 Super Bowl Sunday is the holy grail of advertising thanks to its massive viewership, with an average of…
MMedication Read More Hims and Hers Health’s compounded Wegovy pill offering fuels market jittersFebruary 5, 2026 Feb 5 (Reuters) – Hims & Hers said it would begin offering compounded versions of Novo Nordisk’s Wegovy…